MRTX

Mirati Therapeutics, Inc. Common Stock
MRTX

Overview Fund Activity
Delisted

MRTX was delisted on the 22nd of January, 2024.

Back to rankings

15 hedge funds and large institutions have $92.1M invested in Mirati Therapeutics, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.49%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BBA
1
Baker Bros. Advisors
New York
$30M
2
TCM
2
Tang Capital Management
California
$17.9M
3
O
3
OrbiMed
New York
$17.4M
4
RCM
4
RA Capital Management
Massachusetts
$8.36M
5
BI
5
BVF Inc
California
$8.26M

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
BBA
1
Baker Bros. Advisors
New York
$30M 1,980,074 +1,980,074 New
TCM
2
Tang Capital Management
California
$17.9M 1,181,400 +1,181,400 New
O
3
OrbiMed
New York
$17.4M 1,149,332 +1,149,332 New
RCM
4
RA Capital Management
Massachusetts
$8.36M 551,723 +551,723 New
BI
5
BVF Inc
California
$8.26M 545,372 +545,372 New
QF
6
QVT Financial
New York
$6.79M 592,978 +592,978 New
B
7
Bailard
California
$1.03M 68,000 +68,000 New
OTPPB
8
Ontario Teachers' Pension Plan Board
Ontario, Canada
$593K 39,115 +39,115 New
Goldman Sachs
9
Goldman Sachs
New York
$517K 34,147 +34,147 New
Deutsche Bank
10
Deutsche Bank
Germany
$432K 28,627 +28,627 New
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$356K 23,523 +23,523 New
Vanguard Group
12
Vanguard Group
Pennsylvania
$329K 21,732 +21,732 New
U
13
UBS
Switzerland
$139K 9,163 +9,163 New
Wells Fargo
14
Wells Fargo
California
$10K 677 +677 New
TRCT
15
Tower Research Capital (TRC)
New York
$5K 300 +300 New